FDA Approval of Cardiac Valve Devices Implanted in a National Cohort of Pediatric Patients, 2016-2022
Susmitha Wunnava, Timothy A. Miller, Meena Nathan, Florence T. Bourgeois
TL;DR
This study examines which cardiac valve devices approved by the FDA were implanted in children from 2016 to 2022.
Contribution
The study provides a national overview of FDA-approved cardiac valve devices used in pediatric patients over a six-year period.
Findings
The FDA approval status of implanted cardiac valve devices was analyzed in a national pediatric cohort.
Findings highlight the types of devices used in pediatric cardiac surgery during 2016-2022.
The study contributes data on device approval and usage in pediatric cardiology.
Abstract
This cohort study evaluates the FDA approval status of cardiac valve devices implanted in pediatric patients.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical studies and practices · Cardiac pacing and defibrillation studies · Pharmaceutical Economics and Policy